Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

MMWR Recomm Rep. 2001 Apr 20;50(RR-4):1-44.

Abstract

This report updates the 2000 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 2000;49[No. RR-3]:1-38). The 2001 recommendations include new or updated information regarding a) the cost-effectiveness of influenza vaccination; b) the influenza vaccine supply; c) neuraminidase-inhibitor antiviral drugs; d) the 2001-2002 trivalent vaccine virus strains, which are A/Moscow/10/99 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Sichuan/379/99-like strains; and e) extension of the optimal time period for vaccination through November. A link to this report and other information regarding influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC at <http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm>.

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Cost of Illness
  • Cost-Benefit Analysis
  • Disease Outbreaks / prevention & control
  • Humans
  • Infant
  • Influenza Vaccines* / administration & dosage
  • Influenza Vaccines* / economics
  • Influenza Vaccines* / supply & distribution
  • Influenza, Human / economics
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Middle Aged
  • Neuraminidase / antagonists & inhibitors
  • Vaccination / standards

Substances

  • Antiviral Agents
  • Influenza Vaccines
  • Neuraminidase